Twitter is fending-off Elon Musk’s takeover intentions with a poison-pill strategy that will make it much more costly for him to buy the company once his holdings exceed 15 percent. Although the Twitter board has yet to formally respond to Musk’s $43 billion offer of $54.20 per share, it is expected to reject it based on the defensive posture  adopted Friday. The poison-pill plan would be in effect for nearly a year, giving Twitter time to find another buyer. While Musk has not detailed how he would fund his offer, word surfaced Monday that Apollo Global Management is evaluating participation. Continue reading Twitter Board Attempts to Block Musk as Equity Firms Circle